radioligand
/ˌreɪdi.oʊˈlaɪɡənd/
Definition
A radioactive molecule that binds specifically to a target biological structure, such as a cell receptor, often used in targeted imaging or therapeutic cancer treatments.
Etymology
Derived from the Latin 'radius' (ray/beam) combined with the Latin 'ligare' (to bind), reflecting the molecule's function of binding to a site while emitting radiation.
In the news
The term is used to describe AdvanCell, a company within Brandon Capital's portfolio that develops radioligand therapy to treat disease by delivering radiation directly to targeted sites. This highlights the firm's broader focus on cutting-edge oncology and medical technologies.
Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics
Read the full article ↗markets.businessinsider.com